2025 annual financial data
Phio Pharmaceuticals 2025 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -9,220,000 USD and net income was -8,698,000 USD.
Operating cash flow was -7,979,000 USD.
Get free Phio Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -9,220,000 USD
- Net income
- -8,698,000 USD
- Operating cash flow
- -7,979,000 USD